Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 160,687 | 54,554 | 136,505 | 76,180 | 30,428 |
| Depreciation Amortization | 13,344 | 6,620 | 28,089 | 20,799 | 13,873 |
| Income taxes - deferred | -7,416 | -6,373 | 2,413 | 7,049 | 8,193 |
| Accounts receivable | -6,402 | -1,881 | 5,335 | 7,662 | 7,444 |
| Accounts payable and accrued liabilities | 1,570 | 1,438 | 641 | -2,481 | -6,266 |
| Other Working Capital | -39,649 | -671 | -30,196 | -32,170 | -46,587 |
| Other Operating Activity | -40,610 | 14,416 | 142,603 | 129,379 | 108,846 |
| Operating Cash Flow | $81,524 | $68,103 | $285,390 | $206,418 | $115,931 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 87,053 | -121,897 | -243,637 | -177,656 | -7,314 |
| PPE Investments | -12,392 | -6,783 | -35,763 | -20,872 | -14,394 |
| Net Acquisitions | N/A | N/A | -82,821 | -82,821 | -82,821 |
| Purchase Of Investment | -4,975 | -4,591 | -18,769 | -7,067 | -3,866 |
| Sale Of Investment | 39,995 | 141,385 | N/A | N/A | N/A |
| Investing Cash Flow | $109,681 | $8,114 | $-380,990 | $-288,416 | $-108,395 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,307 | 1,531 | 16,658 | 11,783 | 11,343 |
| Common Stock Repurchased | -126,623 | -14,517 | N/A | 0 | 0 |
| Other Financing Activity | -12,802 | -10,950 | -18,860 | -18,730 | -12,129 |
| Financing Cash Flow | $-134,118 | $-23,936 | $-2,202 | $-6,947 | $-786 |
| Exchange Rate Effect | -7,570 | -4,607 | -2,090 | 490 | 2,422 |
| Beginning Cash Position | 132,818 | 132,818 | 232,710 | 232,710 | 232,710 |
| End Cash Position | 182,335 | 180,492 | 132,818 | 144,255 | 241,882 |
| Net Cash Flow | $49,517 | $47,674 | $-99,892 | $-88,455 | $9,172 |
| Free Cash Flow | |||||
| Operating Cash Flow | 81,524 | 68,103 | 285,390 | 206,418 | 115,931 |
| Capital Expenditure | -12,392 | -6,783 | -35,763 | -20,872 | -14,394 |
| Free Cash Flow | 69,132 | 61,320 | 249,627 | 185,546 | 101,537 |